It has been shown that neutralization of HMGB1 reduces development of atherosclerosis in apolipoprotein E-deficient mice [38], suggesting significant contribution of decreased HMGB1 by Ipra to the inhibition of vascular remodeling. Here, HMGB1 is linked to atherosclerosis.